420 related articles for article (PubMed ID: 25597383)
1. Second-generation antipsychotic effect on cognition in patients with schizophrenia--a meta-analysis of randomized clinical trials.
Nielsen RE; Levander S; Kjaersdam Telléus G; Jensen SO; Østergaard Christensen T; Leucht S
Acta Psychiatr Scand; 2015 Mar; 131(3):185-96. PubMed ID: 25597383
[TBL] [Abstract][Full Text] [Related]
2. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
3. The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia.
Meltzer HY; McGurk SR
Schizophr Bull; 1999; 25(2):233-55. PubMed ID: 10416729
[TBL] [Abstract][Full Text] [Related]
4. The effect of antipsychotics on the cognitive performance of individuals with psychotic disorders: Network meta-analyses of randomized controlled trials.
Baldez DP; Biazus TB; Rabelo-da-Ponte FD; Nogaro GP; Martins DS; Kunz M; Czepielewski LS
Neurosci Biobehav Rev; 2021 Jul; 126():265-275. PubMed ID: 33812977
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis.
Zhang JP; Gallego JA; Robinson DG; Malhotra AK; Kane JM; Correll CU
Int J Neuropsychopharmacol; 2013 Jul; 16(6):1205-18. PubMed ID: 23199972
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia.
Woodward ND; Purdon SE; Meltzer HY; Zald DH
Int J Neuropsychopharmacol; 2005 Sep; 8(3):457-72. PubMed ID: 15784157
[TBL] [Abstract][Full Text] [Related]
7. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
8. Social cognition and visual perception in schizophrenia inpatients treated with first-and second-generation antipsychotic drugs.
Kucharska-Pietura K; Mortimer A; Tylec A; Czernikiewicz A
Clin Schizophr Relat Psychoses; 2012 Apr; 6(1):14-20. PubMed ID: 22453865
[TBL] [Abstract][Full Text] [Related]
9. Combination of "atypical" antipsychotic medication in the management of treatment-resistant schizophrenia and schizoaffective disorder.
Lerner V; Libov I; Kotler M; Strous RD
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):89-98. PubMed ID: 14687862
[TBL] [Abstract][Full Text] [Related]
10. Neurocognitive effects of first- and second-generation antipsychotic drugs in early-stage schizophrenia: a naturalistic 12-month follow-up study.
Guo X; Zhai J; Wei Q; Twamley EW; Jin H; Fang M; Hu M; Zhao J;
Neurosci Lett; 2011 Oct; 503(2):141-6. PubMed ID: 21888948
[TBL] [Abstract][Full Text] [Related]
11. Disparate effects of first and second generation antipsychotics on cognition in schizophrenia - Findings from the randomized NeSSy trial.
Veselinović T; Scharpenberg M; Heinze M; Cordes J; Mühlbauer B; Juckel G; Habel U; Rüther E; Timm J; Gründer G;
Eur Neuropsychopharmacol; 2019 Jun; 29(6):720-739. PubMed ID: 30981585
[TBL] [Abstract][Full Text] [Related]
12. Novel antipsychotics: issues and controversies. Typicality of atypical antipsychotics.
Stip E
J Psychiatry Neurosci; 2000 Mar; 25(2):137-53. PubMed ID: 10740987
[TBL] [Abstract][Full Text] [Related]
13. Clozapine: a comparison with other novel antipsychotics.
Fleischhacker WW
J Clin Psychiatry; 1999; 60 Suppl 12():30-4. PubMed ID: 10372608
[TBL] [Abstract][Full Text] [Related]
14. The impact of atypical antipsychotic medications on long-term memory dysfunction in schizophrenia spectrum disorder: a quantitative review.
Thornton AE; Van Snellenberg JX; Sepehry AA; Honer W
J Psychopharmacol; 2006 May; 20(3):335-46. PubMed ID: 16174678
[TBL] [Abstract][Full Text] [Related]
15. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
[TBL] [Abstract][Full Text] [Related]
16. Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
Harvey PD; Siu CO; Romano S
Psychopharmacology (Berl); 2004 Mar; 172(3):324-32. PubMed ID: 14615877
[TBL] [Abstract][Full Text] [Related]
17. The effects of clozapine on cognitive functioning in schizophrenia.
McGurk SR
J Clin Psychiatry; 1999; 60 Suppl 12():24-9. PubMed ID: 10372607
[TBL] [Abstract][Full Text] [Related]
18. A double-blind study of combination of clozapine with risperidone in patients with schizophrenia: effects on cognition.
Akdede BB; Anil Yağcioğlu AE; Alptekin K; Turgut TI; Tümüklü M; Yazici MK; Jayathilake K; Tunca Z; Göğüş A; Meltzer HY
J Clin Psychiatry; 2006 Dec; 67(12):1912-9. PubMed ID: 17194269
[TBL] [Abstract][Full Text] [Related]
19. Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder.
Elie D; Poirier M; Chianetta J; Durand M; Grégoire C; Grignon S
J Psychopharmacol; 2010 Jul; 24(7):1037-44. PubMed ID: 19164494
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of the efficacy of second-generation antipsychotics.
Davis JM; Chen N; Glick ID
Arch Gen Psychiatry; 2003 Jun; 60(6):553-64. PubMed ID: 12796218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
